EXOME SEQUENCING IN MEDULLARY SPONGE KIDNEY - Trial NCT06418230
Access comprehensive clinical trial information for NCT06418230 through Pure Global AI's free database. This phase not specified trial is sponsored by Hospices Civils de Lyon and is currently Recruitment Completed. The study focuses on Medulary Sponge Kidney. Target enrollment is 80 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
Hospices Civils de Lyon
Timeline & Enrollment
N/A
Jan 02, 2024
Mar 31, 2025
Primary Outcome
Class 3, 4 and 5 variants detected at exome-sequencing
Summary
Medullary sponge kidney is a rare, underdiagnosed renal pathology, characterized by
 precalyceal dilatation of the renal tubes associated with active and recurrent stone disease
 with nephrocalcinosis, hypercalciuria and tubular dysfunction with, for example,
 acidification and urinary concentration defects.
 
 The pathophysiology is poorly understood The prevalence and etiopathogenesis of the disease
 is not known Medullary sponge kidney is often characterized as a congenital pathology with
 delayed expression due to reported cases occurring in early childhood and associations with
 other congenital renal and extra-renal malformative pathologies, such as Wilms tumors,
 horseshoe kidney, contralateral renal hypoplasia, Beckwith-Wiedemann syndrome, Caroli
 disease, or congenital hepatic fibrosis, for example. However, no clear demonstration of the
 congenital nature has been established so far, and it is considered a sporadic disease.
 
 However familial cases have been reported with an autosomal dominant mode.
 
 The pathophysiology may involve disruptions in renal organogenesis, which depends on
 reciprocal inductive interactions necessary to coordinate nephrogenesis between the ureteric
 bud and the metanephric blastema during the 5th week of embryonic development. Some authors
 suggested that the GDNF and RET genes may be involved in the physiopathology of the disease.
 
 For instance 12% of heterozygous patients for rare GDNF variants were identified in an
 Italian cohort of 57 medullary sponge kidney patients.
 
 Other genes have been suggested to be involved in the pathophysiology based on reported
 cases, with no direct relationship demonstrated and their role remain putative Medullary
 sponge kidney disease is a debilitating condition, with the main symptoms being recurrent
 kidney stones and urinary infections.
 
 Additional data are needed to determine the involvement of genetic anomalies in the
 pathophysiology of the condition.
 
 The aim of the study is to describe the genetic variants identified with exome sequencing in
 medullary sponge kidney patients, in order to optimize management, especially for familial
 forms, and therapeutic interventions.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06418230
Non-Device Trial

